+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sacubitril Valsartan Sodium Drugs Market by Type (Brand, Generic), Strength (24 26 Mg, 49 51 Mg, 97 103 Mg), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079054
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global sacubitril valsartan sodium market is experiencing dynamic transformation, shaped by evolving clinical guidelines, new reimbursement landscapes, and disruptive regulatory shifts. Senior decision-makers can leverage this in-depth research to anticipate trends, understand multi-level segmentation, and adapt strategies in response to recent policy and technology advances.

Market Snapshot: Sacubitril Valsartan Sodium

Sacubitril valsartan sodium has rapidly advanced to a central position in chronic heart failure management, supported by strong clinical adoption and updated cardiology guidelines. The market reflects ongoing integration of innovative fixed-dose combinations, adoption in both brand and generic product types, and wider acceptance across key regional clusters. Growth is reinforced by expanded access strategies, strategic pricing, and technology-enabled care models. Increasing demand from healthcare systems and patient support programs is spurring new investment, while evolving competitive dynamics are reshaping both commercial and operational landscapes.

Scope & Segmentation

This report delivers an incisive overview of the sacubitril valsartan sodium market, analyzing current trends and future outlook across several dimensions:

  • Type: Brand products that benefit from clinician loyalty and established support services, alongside generics that capitalize on pricing competitiveness and accelerated market entry.
  • Strength: Dosing options including 24/26 mg for initiation, 49/51 mg as an intermediate, and 97/103 mg targeting advanced patient requirements.
  • End User: Clinics serving initial diagnoses, hospital units focused on acute and transitional care, and growing home care models enabling remote patient management.
  • Distribution Channel: Hospital pharmacy outlets supporting inpatient needs, retail pharmacies ensuring community access, and online channels enabling direct-to-patient delivery.
  • Regions: Insights across the Americas (notably the United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, Russia, Italy, Spain, key Gulf and African nations), and Asia-Pacific (with leaders such as China, India, Japan, Australia, and regional neighbors).
  • Competitive Landscape: Detailed company analysis covers leading brands and major generic manufacturers such as Novartis AG, Teva Pharmaceutical Industries Ltd, Viatris Inc, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Alembic Pharmaceuticals Ltd, Lupin Ltd, Hetero Labs Limited, and Dr. Reddy’s Laboratories Ltd.
  • Technologies: Advances in bioavailability, remote monitoring platforms, real-time inventory management, and supply chain visibility solutions.

Key Takeaways for Decision-Makers

  • Early clinical integration and broader formulation options are encouraging earlier adoption while supporting tailored patient pathways across dosage strengths.
  • Digital health platforms empower both clinicians and patients, with real-time adherence monitoring, remote consultations, and prompt intervention for heart failure decompensation risks.
  • Strategic payer engagement—including value-dossier development and outcome-linked reimbursement—remains vital for formulary inclusion and to address heightened cost-containment pressures.
  • Competitive strategies are shifting toward portfolio expansion, new fixed-dose combinations, advanced manufacturing collaborations, and robust lifecycle management.
  • Supply chain resilience is now central, with efforts to localize production, diversify APIs, and utilize blockchain-enabled logistics to limit impact from external disruptions.
  • Regional alliances and cross-border knowledge sharing are streamlining regulatory processes and expanding market access, particularly across the Asia-Pacific and EMEA regions.

Tariff Impact: 2025 U.S. Policy Effects

The primary keyword, sacubitril valsartan sodium, encountered significant cost structure changes as a result of U.S. tariff actions in 2025. These measures led manufacturers to reassess sourcing strategies, invest in local production, and intensify dialogue with regulatory bodies. Companies in tariff-impacted markets prioritized agile procurement and supply chain diversification, shaping both near-term strategy and long-term investment. Ongoing monitoring and adaptation are mandatory to insulate market access and maintain pricing stability.

Methodology & Data Sources

The research employs a comprehensive approach, integrating primary interviews with industry experts and secondary data mining from peer-reviewed studies, regulatory filings, and confidential company disclosures. Analytical rigor is achieved through qualitative trend mapping, scenario modeling, and multi-level peer review to ensure actionable insights.

Why This Report Matters

  • Provides an authoritative guide for supply chain resilience, enabling proactive risk management amid geographic and regulatory uncertainty.
  • Supports competitive positioning by revealing critical segmentation and pricing drivers across product, region, and distribution.
  • Empowers strategic planning, equipping leaders to anticipate challenges and act on emerging opportunities with confidence.

Conclusion

The sacubitril valsartan sodium market is characterized by advancing therapies, diverse stakeholders, and a complex policy environment. In-depth segmentation analysis and coverage of regulatory and operational shifts enable informed, strategic decision-making for sustainable market growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased adoption of sacubitril valsartan sodium as firstline therapy in chronic heart failure management
5.2. Intensifying competition from generic valsartan and novel neprilysin inhibitors impacting market share
5.3. Pricing pressure from healthcare payers driving negotiation on reimbursement for sacubitril valsartan sodium
5.4. Real world evidence demonstrating reduction in hospital readmissions influencing prescribing patterns
5.5. Regulatory approvals and market entry strategies for sacubitril valsartan sodium in Asia Pacific markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sacubitril Valsartan Sodium Drugs Market, by Type
8.1. Introduction
8.2. Brand
8.3. Generic
9. Sacubitril Valsartan Sodium Drugs Market, by Strength
9.1. Introduction
9.2. 24 26 Mg
9.3. 49 51 Mg
9.4. 97 103 Mg
10. Sacubitril Valsartan Sodium Drugs Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Sacubitril Valsartan Sodium Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Sacubitril Valsartan Sodium Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sacubitril Valsartan Sodium Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sacubitril Valsartan Sodium Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novartis AG
15.3.2. Teva Pharmaceutical Industries Ltd
15.3.3. Viatris Inc
15.3.4. Zydus Lifesciences Ltd
15.3.5. Torrent Pharmaceuticals Ltd
15.3.6. Aurobindo Pharma Ltd
15.3.7. Alembic Pharmaceuticals Ltd
15.3.8. Lupin Ltd
15.3.9. Hetero Labs Limited
15.3.10. Dr. Reddy’s Laboratories Ltd
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET: RESEARCHAI
FIGURE 24. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 25. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET: RESEARCHCONTACTS
FIGURE 26. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 24 26 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 24 26 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 49 51 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 49 51 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 97 103 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY 97 103 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 59. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. CANADA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 68. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 69. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. MEXICO SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. GERMANY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 118. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 119. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. FRANCE SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ITALY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 142. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 143. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. SPAIN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 174. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. DENMARK SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 190. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 191. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. QATAR SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 198. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FINLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EGYPT SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 230. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 231. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 232. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 233. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. TURKEY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. NORWAY SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 254. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 255. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 256. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 257. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. POLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. CHINA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. INDIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 296. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 298. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 299. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. JAPAN SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA SACUBITRIL VALSARTAN SODIUM DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA SACUBIT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sacubitril Valsartan Sodium Drugs market report include:
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Zydus Lifesciences Ltd
  • Torrent Pharmaceuticals Ltd
  • Aurobindo Pharma Ltd
  • Alembic Pharmaceuticals Ltd
  • Lupin Ltd
  • Hetero Labs Limited
  • Dr. Reddy’s Laboratories Ltd